资讯
5 小时
InsideHook on MSNThe FDA Just Approved an Alzheimer's Disease Blood TestIf you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
美国食品药品监督管理局周五表示,该机构已批准Fujirebio Diagnostics公司的血液检测技术“Lumipulse”用于诊断阿尔茨海默病,成为首个获批的阿尔茨海默氏症血液检测设备。血液检测可以加快疾病的诊断,并使更多的人更容易获得治疗方法。检测阿尔茨海默氏症的其他方法包括脊髓穿刺,这需要侵入性穿刺来收集脊髓液,或者昂贵的PET脑部扫描,健康保险公司可能不会提供报销。返回搜狐,查看更多 平 ...
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
Investing.com — 美国食品药品监督管理局 (FDA)已授权首个基于血液的诊断工具,用于帮助检测出现认知能力下降迹象和症状的成年人的阿尔茨海默病。Lumipulse G pTau217/ß-Amyloid ...
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
2025年5月份,美国食品药品监督管理局(FDA)正式批准了一款由日本生物技术公司 Fujirebio Diagnostics ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.
The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer’s disease. It is approved for use in ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果